Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

20/04/2026 Eastern Time in USA The Dow Jones Industrial Average dropped by 0.01%, closing at 49442.56 points; the Nasdaq Composite dropped by 0.26%, closing at 24404.39 points; the S&P 500 Index dropped by 0.24%, closing at 7109.14 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

RUPERT RESOURCES: Overnight gain 65.8%, Surges on Core Project Progress Amid Strong Gold Market Environment

RUPERT RESOURCES (RUPRF) experienced a remarkable 65.8% overnight surge driven by multiple converging factors. As Finland's leading undeveloped gold mining project operator, the company's substantial gains primarily stem from significant developments in its core projects. Key catalysts include breakthrough advancements in exploration technology, updated resource reserve assessments, and critical project development milestones. The robust gold market environment has created favorable conditions for mining equities, with RUPERT RESOURCES (RUPRF) delivering an impressive 85.3% year-to-date gain, reflecting strong market confidence in its long-term value proposition. Finland's stable political environment, comprehensive infrastructure, and supportive regulatory framework have further bolstered investor sentiment toward the company's growth prospects. The combination of institutional capital flows targeting premium gold assets and positive fundamental developments has collectively driven the stock's exceptional performance, positioning RUPERT RESOURCES (RUPRF) as a standout performer in the precious metals sector.

Julong Holding Limited Class A: Overnight gain 48.7%, Surges Amid Smart City Demand and Digital Transformation Growth

Julong Holding Limited is an exempted company with limited liability incorporated under the laws of the Cayman Islands on August 7, 2023, with its principal operations conducted through its operating subsidiaries in mainland China. The Company's operating entity, Julong Online (Beijing) Technology Development Co., Ltd., is a certified National High-tech Enterprise specializing in intelligent building system integration, information network system integration, fire protection linkage system integration, and comprehensive internet services. The entity also undertakes large-scale engineering decoration, curtain wall, mechanical and electrical installation, and general contracting projects.

Notably, the surge in Julong Holding Limited Class A (JLHL) stock price resulted from multiple converging factors. As a national high-tech enterprise, the company's specialized advantages in building intelligent system integration and information network system integration align with current market demands for smart city construction and digital transformation. Its diversified technical service capabilities and integrated engineering general contracting business model provide comprehensive solutions for clients, effectively enhancing market competitiveness. At the industry level, the building intelligence market continues expanding while demand for information network system integration remains robust, creating favorable external conditions for the company's business development. The 48.7% single-day gain and 134.2% year-to-date cumulative increase reflect investors' positive expectations regarding the company's technological innovation capabilities and business expansion prospects. The market has assigned high valuations to its growth potential within the digital economy wave.

SIVERS SEMICONDUCTORS AB: Overnight gain 42.1%, Surges Amid Semiconductor Recovery and Strong Investor Confidence

**SIVERS SEMICONDUCTORS AB (SIVEF) Surges on Multiple Catalysts** SIVERS SEMICONDUCTORS AB (SIVEF) experienced remarkable gains driven by multiple converging factors. The stock surged 42.1% overnight, accumulating an impressive 397.6% year-to-date return, demonstrating exceptional market performance. As a semiconductor technology specialist, SIVERS SEMICONDUCTORS AB (SIVEF) benefits from the current industry recovery cycle. Technical analysis reveals that consecutive substantial gains reflect strong investor confidence in the company's future prospects, with significant capital inflows sustaining upward momentum. Fundamentally, the company appears to have achieved breakthrough progress in core technology development, strategic client partnerships, or operational performance. Semiconductor innovation typically triggers valuation repricing, particularly amid emerging applications in 5G and IoT sectors. Current market conditions favor growth-oriented semiconductor companies with premium valuations. Investors demonstrate willingness to pay higher prices for growth potential and technological advantages, creating a positive feedback loop driving continued price appreciation for SIVERS SEMICONDUCTORS AB (SIVEF).

COMPASS Pathways Plc Sponsored ADR: Overnight gain 42.0%, Surges on Trump PTSD Research Executive Order Boosting Psychedelic Sector

COMPASS Pathways plc was incorporated in June 2020 as a private limited company under the laws of England and Wales. The company is positioned as a biotechnology enterprise focused on the research and development of evidence-based innovative mental health treatment solutions for patients. The company's core business centers around its investigational product COMP360 psilocybin therapy, which aims to establish a new treatment paradigm for mental health disorders characterized by rapid and durable therapeutic outcomes. This therapy has the potential to become a first-in-class product in its therapeutic category. COMP360 represents the company's proprietary psilocybin formulation, utilizing pharmaceutical-grade polymorphic crystalline psilocybin technology with professional optimization for enhanced product stability and purity.

COMPASS Pathways Plc Sponsored ADR (CMPS) shares surged following President Trump's executive order accelerating PTSD research, delivering significant policy tailwinds for the psychedelics industry. The executive order specifically targets accelerated development of post-traumatic stress disorder therapies and expanded treatment access, with multiple investment bank analysts characterizing it as a "structural inflection point" for the U.S. psychedelics sector. Oppenheimer analysts view this as representing a structural industry turning point, highlighting COMPASS Pathways' differentiated advantages. Jefferies analysts noted that government alignment will significantly enhance investor attention and accelerate commercialization timelines. RBC analysts indicated this initiative positions psychedelics as key mental health therapeutics. As a pioneering company in psychedelic therapeutics, COMPASS Pathways leverages its proprietary COMP360 psilocybin formulation, offering technical advantages in stability and purity. The policy support clarifies the company's 2027-2030 drug approval pathway, substantially improving commercialization prospects.

Beyond Meat: Overnight gain 41.0%, Surges on Product Innovation Breakthrough and Strategic Distribution Expansion

Beyond Meat, Inc. was incorporated on April 8, 2011, as a Delaware corporation. The company operates as a leading enterprise in the plant-based meat alternatives sector, specializing in the development and commercialization of plant-based protein products that replicate the taste, texture, and culinary experience of traditional animal meat. The company's product portfolio encompasses three primary categories: beef, pork, and poultry alternatives. Beyond Meat maintains a diversified distribution network spanning retail grocery chains, major retail outlets, membership warehouse clubs, and foodservice establishments. As a key player in the emerging food technology industry, the company is positioned to deliver sustainable protein solutions to consumers, addressing the growing demand for alternative protein sources in the global marketplace.

**Beyond Meat (BYND) Stock Surges on Multiple Positive Catalysts** Beyond Meat (BYND) shares experienced significant upward momentum driven by several favorable developments. The company achieved a breakthrough in product innovation with the nationwide launch of its Beyond Breakfast Sausage line, marking its first Clean Label Project-certified product that emphasizes health and ingredient transparency. The product will be distributed through major retailers including Kroger and Sprouts Farmers Market, with Whole Foods Market expected to follow. Channel expansion efforts yielded substantial results as Beyond Meat (BYND) secured a distribution agreement with Big Geyser, one of America's largest non-alcoholic beverage distributors. This partnership extends Beyond Immerse functional beverages from direct-to-consumer channels into New York markets, leveraging Big Geyser's extensive network of over 26,000 retail outlets. The market has positively received the company's strategic diversification from traditional plant-based meat products into adjacent categories like functional beverages, viewing this as a proactive response to industry headwinds. Additionally, Iran's assurance of keeping the Strait of Hormuz open during ceasefire periods alleviated energy cost concerns, benefiting the broader food industry.

Innventure, Inc.: Overnight gain 34.6%, Surges on Subsidiary's Breakthrough Cooling Solution for AI Data Centers

**Innventure, Inc. Focuses on Transformative Sustainable Technology Solutions Through Strategic Acquisitions and Licensing** Innventure, Inc., a Delaware-incorporated corporation, specializes in founding, funding, and operating companies that develop transformative sustainable technology solutions. The company primarily conducts business through acquisitions or licensing agreements with multinational corporations for their proprietary technologies. Operating as an owner-operator, Innventure employs a proprietary risk management framework specifically designed for disruptive enterprises with breakthrough technologies, targeting companies with potential valuations of at least $1 billion. The company's operational scope encompasses end-to-end management from early-stage technology assessment through scaled commercial operations. Innventure defines "disruptive" technologies as innovations with the capability to significantly transform how businesses, industries, markets, and consumers operate. Through this strategic positioning, the company is committed to identifying and nurturing technology solutions with market transformation potential, while maximizing commercial value through systematic operational management. The company's business model represents a comprehensive approach to technology commercialization, combining strategic capital deployment with operational expertise to scale transformative innovations across multiple sectors.

Innventure, Inc. (INV) shares surged 34.6% following the breakthrough product launch by its subsidiary Accelsius. The company unveiled NeuCool® IR150, the industry's first fully integrated rack-level cooling solution featuring 150kW capacity design. This innovative system integrates two-phase cooling distribution units, 42U IT rack space, and built-in liquid and vapor manifolds within a single 800mm-wide cabinet, enabling plug-and-play functionality. The technological advancement extends two-phase liquid cooling technology from hyperscale data centers to enterprise and smaller operator markets, significantly expanding the potential customer base. The product launch coincides with a critical inflection point in the data center industry, as hyperscale and emerging cloud operators rapidly deploy gigawatt-scale AI facilities, driving surging demand for efficient cooling solutions. The simultaneous introduction of the NeuCool HyperStart program further validates the company's commercialization prospects, contributing to the substantial stock price appreciation.

NRX Pharmaceuticals, Inc.: Overnight gain 25.5%, Surges Amid Presidential Executive Order Supporting Psychedelic Drug Access

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company incorporated under Delaware law on May 20, 2015. Through its wholly-owned operating subsidiary NeuroRx, Inc., the company focuses on the development and commercialization of therapeutic treatments for central nervous system disorders, with its primary therapeutic areas encompassing the development of innovative therapies for indications including suicidal depression, chronic pain, post-traumatic stress disorder, and schizophrenia.

NRX Pharmaceuticals, Inc. (NRXP) shares surged 25.5% following the announcement of a new presidential executive order that signals significant policy tailwinds for the company's core business operations. The executive order explicitly supports accelerated medical treatment for severe mental illnesses, specifically mentioning the need to "increase access to life-saving psychedelic drugs," which directly aligns with NRX Pharmaceuticals' strategic focus. As a biopharmaceutical company specializing in central nervous system disorders, NRX is developing innovative therapies for suicidal depression, chronic pain, and post-traumatic stress disorder. The order's emphasis on "accelerating innovative research models and drug approval processes" is expected to create a more favorable regulatory environment for the company's product approval pipeline, potentially shortening the timeline from development to commercialization. Market analysts widely view this policy shift as significantly enhancing the company's commercial value and profitability outlook, driving the substantial single-day stock appreciation.

AEVEX Corp. Class A: Overnight gain 24.1%, Surges on NYSE IPO Debut Amid Defense Tech Focus

AEVEX Corp., a Delaware-incorporated defense technology prime contractor and unmanned systems provider established on October 27, 2025, specializes in delivering autonomous, AI-enabled unmanned systems solutions to government and allied partner clients. The company's product portfolio encompasses unmanned aerial systems (UAS) and unmanned surface vessels (USV), supported by mission-critical software development capabilities focused on precision strike operations, loitering munitions, and comprehensive intelligence, surveillance, and reconnaissance (ISR) missions. The corporation has demonstrated extensive operational experience in large-scale combat deployment delivery and support services, with its solutions having undergone combat validation to establish proven battlefield effectiveness and operational performance metrics.

**AEVEX Corp. Class A (AVEX) Surges on Multi-Factor Catalyst Convergence** AEVEX Corp. Class A (AVEX) experienced significant price appreciation driven by multiple positive catalysts. The company successfully completed its NYSE IPO at $20 per share, surging 24.1% to $26.93 on debut, demonstrating classic IPO momentum with substantial capital inflows. AEVEX positions itself as a defense technology prime contractor specializing in unmanned systems and AI-enabled autonomous platforms, capitalizing on the current defense technology investment cycle. The company maintains an established government client base including the U.S. Department of Defense and Special Operations Forces, with product portfolios spanning precision strike systems and unmanned surface vessels across multiple high-technology sectors, featuring proven battlefield effectiveness. The convergence of successful public market entry, strategic positioning in high-demand defense technology segments, validated operational capabilities with government contracts, and enhanced executive market engagement activities has collectively strengthened investor confidence and driven the stock's upward trajectory.

Soluna Holdings: Overnight gain 23.9%, Surges Amid Strategic Acquisition Completion and Renewable Computing Expansion Plans

**Soluna Holdings Leverages Renewable Computing Model to Bridge Clean Energy and High-Performance Computing Demand** Soluna Holdings, Inc., originally incorporated in New York in 1961, completed its reincorporation in Nevada in March 2021. The company specializes in developing, owning, and operating digital infrastructure through the co-location integration of data centers with renewable energy generation facilities, providing service support for high-energy computing applications. The company has defined this business model as "renewable computing," designed to address the convergence of two significant market trends: the continued decline in renewable energy generation costs and the rapid growth in demand for power-intensive computing applications, including artificial intelligence, high-performance computing, and Bitcoin mining operations. By deploying data centers in proximity to renewable energy generation assets, Soluna Holdings aims to convert underutilized clean energy into cost-effective computing processing capacity, thereby achieving optimal allocation and efficient utilization of energy resources. This strategic approach positions the company to capitalize on the growing intersection between sustainable energy infrastructure and the expanding computational requirements of emerging technologies.

Soluna Holdings (SLNH) shares surged following the completion of a significant strategic acquisition. The company acquired the remaining stake in Project Dorothy 1A from Spring Lane Capital for $16.5 million, securing full control of the project and substantially strengthening its strategic positioning in the renewable computing sector. The acquisition coincides with secured financing for data center expansion, providing essential capital support for business growth. As an innovative enterprise specializing in integrating data centers with renewable energy power plants, Soluna Holdings (SLNH) is strategically positioned to capitalize on rapidly growing artificial intelligence and high-performance computing demands, alongside expanding renewable energy generation capacity. The 23.9% single-day gain reflects positive investor sentiment toward the company's strategic acquisition and expansion plans, demonstrating confidence in its growth prospects within the emerging renewable computing sector. This market response underscores investor optimism regarding Soluna Holdings' (SLNH) ability to leverage the convergence of renewable energy and computational infrastructure demands.

LifeMD: Overnight gain 23.7%, Surges Amid Telemedicine Growth and Integrated Healthcare Ecosystem Competitive Advantages

**LifeMD: Comprehensive Direct-to-Patient Telemedicine Platform** Established in 1994, LifeMD, Inc. operates as a direct-to-patient telemedicine services provider, delivering convenient and comprehensive virtual and at-home healthcare solutions through high-quality, cost-effective offerings. The company leverages its proprietary technology platform, extensive network of healthcare providers, comprehensive treatment capabilities, and superior patient relationship management to continuously enhance the telemedicine service experience. LifeMD's integrated telemedicine platform encompasses multiple core functional modules, including: a medical group with coverage across all 50 U.S. states, a nationwide pharmacy network, a wholly-owned commercial pharmacy operation, national laboratory and diagnostic testing services, a fully integrated electronic health records (EHR) management system, and specialized patient care and customer service call centers. This comprehensive infrastructure creates a complete healthcare services ecosystem. The company's vertically integrated approach positions it to serve patients throughout the entire healthcare journey, from initial consultation through prescription fulfillment and ongoing care management.

**LifeMD(LFMD) Stock Surge Driven by Multiple Favorable Catalysts** LifeMD(LFMD) shares have experienced significant appreciation due to converging positive factors. The telemedicine sector is experiencing rapid expansion in the post-pandemic era, with sustained growth in consumer demand for convenient healthcare services. LifeMD(LFMD) maintains distinct competitive advantages through its integrated telemedicine ecosystem, encompassing a comprehensive medical network across all 50 states, nationwide pharmacy and laboratory infrastructure, and proprietary technology platforms that seamlessly integrate service offerings. The company's nearly three-decade track record in telemedicine has established substantial industry expertise and distinctive patient relationship management capabilities, providing a solid foundation for market expansion. Against the backdrop of rising healthcare costs, LifeMD(LFMD)'s "high-quality, cost-effective" service model demonstrates compelling market competitiveness. The stock's impressive 48.4% year-to-date gains reflect capital markets' positive sentiment toward the company's business model and favorable industry outlook, underscoring investor confidence in the telemedicine sector's growth trajectory.

The Top 10 Daily Gainers in the USA market are listed as follows:

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team. Risk and Disclaimer: The content provided above is solely for informational purposes and does not represent the views or positions of Sahm Platform. While we strive for accuracy, we cannot guarantee the authenticity or completeness of the information contained in the provided content. We strongly recommend that investors consult with a qualified investment advisor when deemed necessary. Sahm Platform neither provides investment advice nor makes any representations or warranties concerning the accuracy, reliability, or completeness of the information in the content provided above. By using Sahm Platform, you acknowledge that you have read, understood, and agreed to the terms set forth in this disclaimer.